Development of iron status and response to iron medication in pubertal boys

R Anttila1, M A Siimes

  • 1Children's Hospital, University of Helsinki, Finland.

Insights

Iron deficiency is a risk for growing boys during puberty. Assessment requires considering age and development, not just lab results, to ensure adequate iron status.

Area of Science:

  • Pediatric endocrinology
  • Nutritional science
  • Hematology

Background:

  • Male puberty involves rapid growth, increasing iron demands.
  • Assessing iron deficiency in adolescents is challenging, with reported prevalences varying widely.
  • Existing criteria may not fully capture the nuances of iron status during pubertal development.

Purpose of the Study:

  • To investigate iron status changes in boys during puberty.
  • To correlate iron parameters with pubertal stage, age, and growth.
  • To evaluate the effectiveness of iron supplementation in pubertal boys.

Main Methods:

  • Longitudinal study of 60 prepubertal/early pubertal boys over 24 months.
  • Bi-annual testing of hemoglobin, ferritin, and transferrin levels.
  • Correlation of iron parameters with Tanner genital stages (G1-G5) and age.

Main Results:

  • Hemoglobin increased significantly starting at genital stage G4.
  • Ferritin levels decreased in early puberty (G1-G3), suggesting a physiological adaptation.
  • Iron deficiency prevalence increased with age and pubertal progression.
  • Iron supplementation improved iron status parameters, confirming limitations due to deficiency.

Conclusions:

  • Iron deficiency evaluation in pubertal boys needs a holistic approach.
  • Consider age, pubertal development, and growth alongside laboratory markers.
  • Early ferritin decline may be adaptive, not necessarily indicative of deficiency.

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...